These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3130900)

  • 1. TSH and catecholamine response to TRH in panic disorder.
    Castellani S; Quillen MA; Vaughan DA; Hund MA; Ho L; Ziegler MG; Le Vine WR
    Biol Psychiatry; 1988 May; 24(1):87-90. PubMed ID: 3130900
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced TSH and prolactin responses to TRH in patients with panic disorder.
    Roy-Byrne PP; Uhde TW; Rubinow DR; Post RM
    Am J Psychiatry; 1986 Apr; 143(4):503-7. PubMed ID: 3082224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TSH response to TRH in depression with and without panic attacks.
    Gillette GM; Garbutt JC; Quade DE
    Am J Psychiatry; 1989 Jun; 146(6):743-8. PubMed ID: 2499197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Panic disorders: clinical update 1984. Neuroendocrine aspects.
    Rubin RT
    Psychosomatics; 1984 Oct; 25(10 Suppl):21-6. PubMed ID: 6390481
    [No Abstract]   [Full Text] [Related]  

  • 5. Sympathetic nervous system activity in panic disorder.
    Villacres EC; Hollifield M; Katon WJ; Wilkinson CW; Veith RC
    Psychiatry Res; 1987 Aug; 21(4):313-21. PubMed ID: 3628614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Panic disorder, vertigo, and the protirelin (TRH) test.
    Hamlin CL
    Psychiatry Res; 1988 Mar; 23(3):349-50. PubMed ID: 3133685
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanisms of anxiogenic vulnerability in panic disorder.
    Targum SD
    Psychiatry Res; 1990 Feb; 31(2):215-6. PubMed ID: 2326400
    [No Abstract]   [Full Text] [Related]  

  • 8. Thyrotropin and prolactin responses to protirelin (TRH) prior to and during chronic imipramine treatment in patients with panic disorder.
    Stein MB; Uhde TW
    Psychoneuroendocrinology; 1990; 15(5-6):381-9. PubMed ID: 2129312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical growth-hormone responses to thyrotropin-releasing hormone in panic disorder.
    Tancer ME; Stein MB; Uhde TW
    Biol Psychiatry; 1990 Jun; 27(11):1227-30. PubMed ID: 2112960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of thyrotropin-releasing hormone at weekly intervals results in a diminished thyrotropin response.
    Winokur A; Caroff SN; Amsterdam JD; Maislin G
    Biol Psychiatry; 1984 May; 19(5):695-702. PubMed ID: 6428472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyrotropin and prolactin responses to different doses of thyrotropin-releasing hormone in depression.
    Masturzo P; Tosca P; Murialdo G; Somenzini G; Cairoli S; Filippi U; De Palma D; Balbi D; Zerbi F
    Neuropsychobiology; 1989; 20(3):120-5. PubMed ID: 2503767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyrotropin stimulating hormone response to thyrotropin releasing hormone in patients with panic disorder.
    Tükel R; Kora K; Hekim N; Oğuz H; Alagöl F
    Psychoneuroendocrinology; 1999 Feb; 24(2):155-60. PubMed ID: 10101724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin and TSH responses to TRH and to ECT in pre- and postmenopausal women with major depression.
    Markianos M; Lykouras L; Stefanis C
    Biol Psychiatry; 1996 Sep; 40(5):403-6. PubMed ID: 8874842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of TSH response to TRH as an independent variable.
    Loosen PT; Kistler K; Prange AJ
    Am J Psychiatry; 1983 Jun; 140(6):700-3. PubMed ID: 6405637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotropin-releasing hormone increases plasma norepinephrine in man.
    Morley JE; Tuck ML; Mayes DM; Rosenblatt S; Hershman JM
    Horm Res; 1981; 14(1):18-23. PubMed ID: 6790402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet imipramine binding in patients with panic disorder and major familial depression.
    Pecknold JC; Chang H; Fleury D; Koszychi D; Quirion R; Nair NP; Suranyi-Cadotte BE
    J Psychiatr Res; 1987; 21(3):319-26. PubMed ID: 3681766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid-stimulating hormone and prolactin responses to thyrotropin-releasing hormone during infusion of epinephrine and propranolol in man.
    Rogol AD; Reeves GD; Varma MM; Blizzard RM
    Neuroendocrinology; 1979; 29(6):413-7. PubMed ID: 118391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine, cardiovascular, and behavioral effects of intravenous protirelin in patients with panic disorder.
    Stein MB; Uhde TW
    Arch Gen Psychiatry; 1991 Feb; 48(2):148-56. PubMed ID: 1899183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenergic status in anxiety disorders: platelet alpha 2-adrenergic receptor binding, blood pressure, pulse, and plasma catecholamines in panic and generalized anxiety disorder patients and in normal subjects.
    Cameron OG; Smith CB; Lee MA; Hollingsworth PJ; Hill EM; Curtis GC
    Biol Psychiatry; 1990 Jul; 28(1):3-20. PubMed ID: 2165422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TSH response to TRH and endogenous dopamine activity.
    Spoov J
    Psychiatry Res; 1988 Apr; 24(1):117-8. PubMed ID: 3134666
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.